HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antigen-specific T-lymphocyte function after cord blood transplantation.

Abstract
It has not been possible to determine the singular contribution of naive T lymphocytes to antigen-specific immunity after hematopoietic stem cell transplantation (HSCT), because of the confounding effects of donor-derived antigen-specific T lymphocytes present in most hematopoietic stem cell (HSC) products. Because umbilical cord blood contains only naive T lymphocytes, we longitudinally evaluated the recipients of unrelated cord blood transplantation (UCBT) for the presence of T lymphocytes with specificity for herpesviruses, to determine the contribution of the naive T lymphocytes to antigen-specific immune reconstitution after HSCT. Antigen-specific T lymphocytes were detected early after UCBT (herpes simplex virus on day 29; cytomegalovirus on day 44; varicella zoster virus on day 94). Overall, 66 of 153 UCBT recipients developed antigen-specific T lymphocytes to 1 or more herpesviruses during the evaluation period. The likelihood of developing antigen-specific T lymphocyte function was not associated with immunophenotypic T lymphocyte reconstitution, transplant cell dose, primary disease, or acute and chronic graft-versus-host disease. These results indicate that naive T lymphocytes present in the HSC inoculum can contribute to the generation of antigen-specific T-lymphocyte immunity early after transplantation.
AuthorsGeoff Cohen, Shelly L Carter, Kenneth I Weinberg, Bernadette Masinsin, Eva Guinan, Joanne Kurtzberg, John E Wagner, Nancy A Kernan, Robertson Parkman
JournalBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation (Biol Blood Marrow Transplant) Vol. 12 Issue 12 Pg. 1335-42 (Dec 2006) ISSN: 1083-8791 [Print] United States
PMID17162216 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antibodies, Viral
Topics
  • Adolescent
  • Antibodies, Viral (blood)
  • Cell Lineage
  • Child
  • Child, Preschool
  • Clinical Trials, Phase II as Topic (statistics & numerical data)
  • Cord Blood Stem Cell Transplantation
  • Cytomegalovirus (immunology, physiology)
  • Cytomegalovirus Infections (diagnosis, immunology, prevention & control, virology)
  • False Negative Reactions
  • Female
  • Fetal Blood (immunology)
  • Follow-Up Studies
  • Graft vs Host Disease (etiology, immunology)
  • Herpes Simplex (diagnosis, immunology, prevention & control, virology)
  • Herpes Zoster (diagnosis, immunology, prevention & control, virology)
  • Herpesvirus 3, Human (immunology, physiology)
  • Humans
  • Infant
  • Infant, Newborn
  • Infections (immunology, mortality)
  • Male
  • Multicenter Studies as Topic (statistics & numerical data)
  • Postoperative Complications (immunology, mortality)
  • Postoperative Period
  • Simplexvirus (immunology, physiology)
  • T-Cell Antigen Receptor Specificity
  • T-Lymphocyte Subsets (immunology)
  • Time Factors
  • Treatment Outcome
  • Virus Activation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: